Marco Montagna

Summary

Affiliation: University of Padova
Country: Italy

Publications

  1. ncbi request reprint Identification of BRCA1 and BRCA2 carriers by allele-specific gene expression (AGE) analysis
    Marco Montagna
    Department of Oncology and Surgical Sciences, Oncology Section, University of Padova, Padova, Italy
    Int J Cancer 98:732-6. 2002
  2. pmc Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
    Antonis C Antoniou
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK
    Breast Cancer Res 14:R33. 2012
  3. pmc Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
    Anna Marie Mulligan
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
    Breast Cancer Res 13:R110. 2011
  4. pmc Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1
    Elisabetta Ricci
    Department of Oncology and Surgical Sciences, Oncology Section, AIDS Reference Center, University of Padova, Via Gattamelata 64, 35128 Padova, Italy
    J Transl Med 8:49. 2010
  5. ncbi request reprint Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families
    Marco Montagna
    IST Genova c o, Azienda Ospedaliera, Padua, Italy
    Hum Mol Genet 12:1055-61. 2003
  6. ncbi request reprint Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations
    Simona Agata
    Department of Oncology and Surgical Sciences, Oncology Section, University of Padua, Padua, Italy
    Genes Chromosomes Cancer 45:791-7. 2006
  7. doi request reprint BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy
    Sandro Malacrida
    Department of Oncology and Surgical Sciences, Oncology Section, IRCCS, Padua, Italy
    J Clin Oncol 26:26-31. 2008
  8. ncbi request reprint Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1 -/- epithelial ovarian cancers
    Stefano Indraccolo
    Istituto Oncologico Veneto, Padova, Italy
    Eur J Cancer 42:1475-83. 2006
  9. doi request reprint Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation
    Maria Chiara Scaini
    Section of Oncology, Department of Oncology and Surgical Sciences, University of Padova, Via Gattamelata, 64, I 35128 Padova, Italy
    Mutat Res 671:26-32. 2009
  10. ncbi request reprint Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents
    Pierfrancesco Tassone
    Oncology Division, Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy
    Int J Oncol 26:1257-63. 2005

Collaborators

  • Laura Cortesi
  • Paolo Radice
  • GianMaria Miolo
  • Stefano Indraccolo
  • Silvia Ferrari
  • Giovanni Esposito
  • Massimo De Paoli
  • Graham J Mann
  • Giovanni Parmigiani
  • Pierfrancesco Tassone
  • Donato Nitti
  • Paolo Aretini
  • Emma D'Andrea
  • Simona Agata
  • Siranoush Manoukian
  • Sandro Malacrida
  • Chiara Menin
  • Maria Chiara Scaini
  • Alessandra Viel
  • Antonis C Antoniou
  • Bernard Peissel
  • Monia Callegaro
  • Encarna B Gomez Garcia
  • Christian F Singer
  • Rosa B Barkardottir
  • Patricia A Ganz
  • Anneliese Fink-Retter
  • Amanda E Toland
  • Dorothea Gadzicki
  • Noralane M Lindor
  • Britta Fiebig
  • Jenny Gross
  • Karin Kast
  • Susan L Neuhausen
  • Heli Nevanlinna
  • Anne Bine Skytte
  • Daniela Zaffaroni
  • John L Hopper
  • Barbara Wappenschmidt
  • Torben A Kruse
  • Susan Peock
  • Claudine Isaacs
  • Laura Papi
  • Christian Sutter
  • Finn C Nielsen
  • Anne Marie Gerdes
  • Daniel Barrowdale
  • Zachary Fredericksen
  • Bernardo Bonanni
  • Irene L Andrulis
  • Dieter Schäfer
  • Raymonda Varon-Mateeva
  • Dieter Niederacher
  • Georgia Chenevix-Trench
  • Lesley McGuffog
  • Ros Eeles
  • Jacques Simard
  • Hilmi Ozcelik
  • Norbert Arnold
  • Julian Adlard
  • Rita K Schmutzler
  • Jackie Cook
  • Isabelle Mortemousque
  • Beth Y Karlan
  • Fiona Lalloo
  • D Gareth Evans
  • Christoph Engel
  • Maria A Caligo
  • Conxi Lazaro
  • Sylvie Mazoyer
  • Juul Wijnen
  • Sue Healey
  • Ignacio Blanco
  • Ana Osorio
  • Vernon S Pankratz
  • Esther M John
  • Dominique Stoppa-Lyonnet
  • David Goldgar
  • Helmut Deissler
  • Mads Thomassen
  • Mercedes Duran
  • Miguel de la Hoya
  • Fergus J Couch
  • Debra Frost
  • Hanne E J Meijers-Heijboer
  • Per Karlsson
  • Brita Arver
  • Trinidad Caldes
  • Loris Bernard
  • Ute Hamann

Detail Information

Publications14

  1. ncbi request reprint Identification of BRCA1 and BRCA2 carriers by allele-specific gene expression (AGE) analysis
    Marco Montagna
    Department of Oncology and Surgical Sciences, Oncology Section, University of Padova, Padova, Italy
    Int J Cancer 98:732-6. 2002
    ..Notably, other hereditary diseases whose genetic analysis is hampered by similar problems could benefit from this kind of approach...
  2. pmc Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
    Antonis C Antoniou
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK
    Breast Cancer Res 14:R33. 2012
    ..2)...
  3. pmc Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
    Anna Marie Mulligan
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
    Breast Cancer Res 13:R110. 2011
    ..It is currently unknown how these alleles are associated with different breast cancer subtypes in BRCA1 and BRCA2 mutation carriers defined by estrogen (ER) or progesterone receptor (PR) status of the tumour...
  4. pmc Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1
    Elisabetta Ricci
    Department of Oncology and Surgical Sciences, Oncology Section, AIDS Reference Center, University of Padova, Via Gattamelata 64, 35128 Padova, Italy
    J Transl Med 8:49. 2010
    ..The aim of this study was to investigate the influence of genetic variants of TLR 9 gene on MTCT...
  5. ncbi request reprint Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families
    Marco Montagna
    IST Genova c o, Azienda Ospedaliera, Padua, Italy
    Hum Mol Genet 12:1055-61. 2003
    ..We therefore propose to systematically include MLPA in the BRCA1 mutational analysis of breast/ovarian cancer families...
  6. ncbi request reprint Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations
    Simona Agata
    Department of Oncology and Surgical Sciences, Oncology Section, University of Padua, Padua, Italy
    Genes Chromosomes Cancer 45:791-7. 2006
    ..11 < 0.19 < 0.28) of the BRCA1 mutation positive families. We conclude that the search for major genomic rearrangements is essential for an accurate and comprehensive BRCA1 mutation detection strategy in Italy...
  7. doi request reprint BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy
    Sandro Malacrida
    Department of Oncology and Surgical Sciences, Oncology Section, IRCCS, Padua, Italy
    J Clin Oncol 26:26-31. 2008
    ..Herein, we investigate the pathogenicity of the BRCA1 p.Val1688del (c.5181_5183delGTT) variant, which recurs in our population...
  8. ncbi request reprint Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1 -/- epithelial ovarian cancers
    Stefano Indraccolo
    Istituto Oncologico Veneto, Padova, Italy
    Eur J Cancer 42:1475-83. 2006
    ..The PD-OVCA1 and PD-OVCA2 ovarian cancer cell lines will provide a valuable tool for new experimental models for the study of BRCA1-associated tumour biology...
  9. doi request reprint Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation
    Maria Chiara Scaini
    Section of Oncology, Department of Oncology and Surgical Sciences, University of Padova, Via Gattamelata, 64, I 35128 Padova, Italy
    Mutat Res 671:26-32. 2009
    ....
  10. ncbi request reprint Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents
    Pierfrancesco Tassone
    Oncology Division, Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy
    Int J Oncol 26:1257-63. 2005
    ....
  11. ncbi request reprint Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations
    Fabio Marroni
    Department of Oncology, Transplants and New Technologies in Medicine, Section of Pathology, University of Pisa, Pisa, Italy
    Eur J Hum Genet 12:899-906. 2004
    ..Our approach could lead to country-customized versions of the BRCAPRO software by providing appropriate population-specific estimates...
  12. ncbi request reprint Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation
    Paolo Aretini
    Section of Oncogenetics, Division of Surgical, Molecular and Ultrastructural Pathology, Department of Oncology, University of Pisa, Pisa, Italy
    Breast Cancer Res Treat 81:71-9. 2003
    ..Proportion of ovarian cancer was increased in the 5' portion of BRCA1, and presence of prostate or pancreatic cancer in a family was correlated with presence of ovarian cancer in BRCA2...
  13. ncbi request reprint Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status
    Chiara Menin
    IST Genova, Azienda Ospedaliera di Padova and Istituto Oncologico Veneto, Padova, Italy
    J Natl Cancer Inst 98:285-8. 2006
    ..0 years, 95% confidence interval = 1.0 to 16.0 years; P = .03 [two-sided Wilcoxon rank sum test]). Our data indicate that MDM2-SNP309 is a modifier of the age at colorectal cancer onset for patients whose tumors have a wild-type p53 gene...
  14. ncbi request reprint The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy
    Maria Adelaide Caligo
    Hum Mutat 24:100-1. 2004